
Bulletin of the Chemical Society of Japan p. 383 - 389 (2000)
Update date:2022-07-30
Topics:
Fujihara, Tetsuaki
Hoshiba, Koji
Sasaki, Yoichi
Imamura, Taira
Reversibility in the formation reaction of a series of the oxo(peroxo)porphyrinatomolybdenums, [Mo(VI)O(tmp)(O2)] 1, [Mo(VI)O(tdcpp)(O2)] 2, [Mo(VI)O(ttp)(O2)] 3, [Mo(VI)O(tdmpp)(O2)] 4, and [Mo(VI)O(tpp)(O2)] 5, was studied. In these dioxygen complexes with various porphyrin rings, two complexes, 2 and 4, were newly prepared by the solid- state reactions of corresponding Mo(IV) complexes with O2. All the complexes were characterized by IR, 1H NMR, and UV- vis spectroscopic measurements. In the reaction of O2 with [Mo(IV)O(tdcpp)] 2r, which has bulky substituents with an electron-withdrawal character, the association rate constant was determined to be 1.2 x 10-2 dm3 mol-1 s-1 in toluene at 20 °C. The value of the rate constant is about one thirtieth of that for [Mo(IV)O(tmp)] 1r, which also has bulky substituents. The result indicates that the electronic effects of the porphyrin rings, which reflect on the redox potentials of the central molybdenum ion, are important in determining kinetic and thermodynamic stability of the dioxygen complexes. All the dioxygen complexes undergo deoxygenation upon photoirradiation to give corresponding [Mo(IV)O(por)]. The redioxy-genation profiles of [Mo(IV)O(por)] in the dark were also significantly affected by the steric bulkiness of the porphyrin ligands. While the bulky porphyrin complexes of 1 and 2 gave full recovery of the dioxygen complexes in the dark, less bulky porphyrin complexes of 3, 4, and 5 undergo some side reactions to Mo(V) species. The rate and extent of the Mo(V) complex formations increase with decreasing steric bulkiness.
View Morewebsite:http://www.truewingroup.com
Contact:86-311-66699812
Address:NO.600 ZHONGSHAN EAST ROAD SHIJIAZHUANG
Zibo Xiaoguang Chemical Material Co., Ltd
Contact:15954099116
Address:Boshan Development Zone
Shanghai Minstar Chemical Co., Ltd
website:http://www.minstargroup.com
Contact:86-21-18019205509
Address:BUILDING 8, NO.1098, CHUANSHA ROAD, SHANGHAI, CHINA
Beijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
Zhejiang Genebest Pharmaceutical Co.,Ltd.
Contact:0086-571-63532866
Address:No.1 Jinboshi Rd Lishan Town Fuyang City Zhejiang Province China
Doi:10.1016/j.jorganchem.2013.11.009
(2014)Doi:10.1021/ja991241d
(2000)Doi:10.1016/S0022-328X(99)00535-5
(2000)Doi:10.1021/ja992513f
(2000)Doi:10.1002/anie.201205352
(2012)Doi:10.1021/jo00800a023
(1971)